Abstract
With advances in stem cell biology, tissue engineering is becoming increasingly powerful for tissue regeneration. Stem cells with capacity of multilineage and self-renewal are an ideal cell source for tissue engineering. This review focus on discussing the potential strategies including stem cell sources, bio-scaffolds, mechanical stimulation, genetic modification and co-culture techniques to direct ocular-lineage differentiation of stem cells for complete or partial eye regeneration and research. Attempts to use embryonic and somatic stem cells as seed cells for ocular tissue engineering have achieved encouraging results. The combination of chemical and physical signals in stem cell microenvironment could be regulated to induce differentiation of the embryonic stem cells into ocular tissue. This paper present here a broad introduction to the stem cell mediated correction of eye ailments and provide extensive references for the interested reader. This paper also looks into the different aspects of using stem cells for drug development for treating eye ailments.
Keywords: optic nerve, drug development, stem cell microenvironment, ocular-lineage differentiation, co-culture techniques, bio-scaffolds, multilineage and self-renewal, tissue regeneration, tissue engineering, stem cell, retina, ocular diseases, eye, Cornea
Current Topics in Medicinal Chemistry
Title: Stem Cells for Ocular Tissue Engineering and Regeneration
Volume: 11 Issue: 13
Author(s): Radhakrishna Gopala Pillai
Affiliation:
Keywords: optic nerve, drug development, stem cell microenvironment, ocular-lineage differentiation, co-culture techniques, bio-scaffolds, multilineage and self-renewal, tissue regeneration, tissue engineering, stem cell, retina, ocular diseases, eye, Cornea
Abstract: With advances in stem cell biology, tissue engineering is becoming increasingly powerful for tissue regeneration. Stem cells with capacity of multilineage and self-renewal are an ideal cell source for tissue engineering. This review focus on discussing the potential strategies including stem cell sources, bio-scaffolds, mechanical stimulation, genetic modification and co-culture techniques to direct ocular-lineage differentiation of stem cells for complete or partial eye regeneration and research. Attempts to use embryonic and somatic stem cells as seed cells for ocular tissue engineering have achieved encouraging results. The combination of chemical and physical signals in stem cell microenvironment could be regulated to induce differentiation of the embryonic stem cells into ocular tissue. This paper present here a broad introduction to the stem cell mediated correction of eye ailments and provide extensive references for the interested reader. This paper also looks into the different aspects of using stem cells for drug development for treating eye ailments.
Export Options
About this article
Cite this article as:
Gopala Pillai Radhakrishna, Stem Cells for Ocular Tissue Engineering and Regeneration, Current Topics in Medicinal Chemistry 2011; 11 (13) . https://dx.doi.org/10.2174/156802611796117559
DOI https://dx.doi.org/10.2174/156802611796117559 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis
Current Alzheimer Research α-Synuclein Misfolding and Neurodegenerative Diseases
Current Protein & Peptide Science Metabolic Control of Glia-Mediated Neuroinflammation
Current Alzheimer Research Nanostructures for Drug Delivery to the Brain
Current Medicinal Chemistry Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
Current Pharmaceutical Design Organoselenium Compounds as Potential Neuroprotective Therapeutic Agents
Current Organic Chemistry Reacting to Stress: Radical Cellular Pathways for Novel Drug Development
Current Neurovascular Research Effect of Electromagnetic Radiations on Neurodegenerative Diseases- Technological Revolution as a Curse in Disguise
CNS & Neurological Disorders - Drug Targets Metallothionein is a Potential Therapeutic Strategy for Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Central Nervous System-Related
Current Bioactive Compounds Is the Cytoskeleton an Intracellular Receptor for Adrenomedullin and PAMP?
Current Protein & Peptide Science Co-Enzyme Q10 to Treat Neurological Disorders: Basic Mechanisms, Clinical Outcomes, and Future Research Direction
CNS & Neurological Disorders - Drug Targets Heat Shock Proteins: Therapeutic Drug Targets for Chronic Neurodegeneration?
Current Pharmaceutical Biotechnology Neurofilament Proteins as Prognostic Biomarkers in Neurological Disorders
Current Pharmaceutical Design Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations
Current Stem Cell Research & Therapy Relevance of Bioassay of Biologically Active Substances (BAS) with Geroprotective Properties in the Model of the Nematode <i>Caenorhabditis Elegans</i> in <i>In Vivo</i> Experiments
Current Aging Science Preliminary Studies on Optimization of Anti-Parkinson Drug Loaded Lipid Nanoparticles Enriched Hydrogel Formulations for Management of Parkinson’s Disease
Current Nanomedicine Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease
Current Pharmaceutical Design In the Rush for Green Gold: Can Green Tea Delay Age-Progressive Brain Neurodegeneration?
Recent Patents on CNS Drug Discovery (Discontinued) Adeno-Associated Virus (AAV) Vectors in the CNS
Current Gene Therapy